Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03939364
Recruitment Status : Withdrawn (Delays due to manufacturing and the COVID-19 pandemic)
First Posted : May 6, 2019
Last Update Posted : October 19, 2021
Information provided by (Responsible Party):
Skyline Biosciences

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : April 2023
Estimated Study Completion Date : May 2023